COPD Clinical Trials

Showing 1221-1240 of 1,622 trials

Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal Block

NCT02466347

The objective of this pivotal study is to evaluate the relative bioavailability of Synflutide HFA 250/25 Inhaler and SeretideTM 250 EvohalerTM in healthy volunteers without charcoal block.

AsthmaChronic Obstructive Pulmonary Disease (COPD)

Intech Biopharm Ltd.45 participantsStarted Jun 2014

New Taipei City, Taiwan

WITHDRAWN

EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients

NCT00361426

Continuous measurement of breathing patterns, heart rate, restlessness and cough in sleep using EarlySense ES 16 device. Predicting worsening in COPD patients' condition using the above parameters.

COPD Patients

EarlySense Ltd.Started Jan 2008

Ramat Gan, Israel

COMPLETEDPhase 2

Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT01587079

The primary objective of this study is to assess the efficacy of Glycopyrrolate/Formoterol Fumarate MDI relative to individual components (GP MDI and FF MDI) in subjects with moderate to severe COPD

Chronic Obstructive Pulmonary Disease

Pearl Therapeutics, Inc.159 participantsStarted Apr 2012

Glendale, Arizona, United States • Rancho Mirage, California, United States • Waterbury, Connecticut, United States +16 more locations

Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal Block

EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients

Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Related Searches

Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation

Perception of Symptom Variability in COPD

Stepping up to Health - for Veterans With Chronic Obstructive Pulmonary Disease (COPD)

Exercise in Health and Chronic Obstructive Pulmonary Disease

Sources of Variability in Peak Expiratory Flow

Longitudinal Study of Cortisol and Pulmonary Function

Developing a COPD Case Finding Methodology for Primary Care

Proteoglycan 4 Mechanism the Effectiveness of Pulmaonry Recovery in COPD Patients

Study to Compare (COPD) Assessment Test in COPD Stage III and IV in a Prophylactic Treatment

BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia

Evaluation of the Lungs of Individuals With Lung Disease

Blood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease

Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke

Effects of Osteopathic Techniques on Residual Volume in Severe Chronic Obstructive Pulmonary Disease

Blood Collection From Individuals With Lung Disease for Genetic Studies

Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State

Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD